What is Klineo?
Klineo operates as an innovative platform designed to provide intuitive and intelligent clinical trial searching specifically for oncology patients and medical professionals. By streamlining access to critical trial information, Klineo aims to accelerate research and improve patient outcomes in the fight against cancer. The company's focus on a specialized and high-impact area of healthcare positions it as a key player in the medical technology sector.
How much funding has Klineo raised?
Klineo has raised a total of $2.1M across 1 funding round:
Other Financing Round
$2.1M
Other Financing Round (2024): $2.1M with participation from BPI France Excellence
Key Investors in Klineo
BPI France Excellence
BPI France Excellence, through its Le Club Excellence network, supports ambitious leaders and fosters innovation. This backing suggests a strategic alignment with companies demonstrating significant growth potential and a forward-thinking approach to market challenges.
What's next for Klineo?
The recent major strategic investment suggests Klineo is entering a phase of accelerated growth and market expansion. This capital infusion is likely to be directed towards enhancing its platform's capabilities, broadening its user base among oncologists and patient advocacy groups, and potentially forging new partnerships within the pharmaceutical and biotech industries. The company's trajectory indicates a strong commitment to advancing clinical trial accessibility and efficiency, a critical need in oncology research.
See full Klineo company page
